Treatment of SIADH Presenting with Seizures or Severe Neurological Symptoms
When SIADH drives acute hyponatremia severe enough to cause seizures, coma, or markedly altered consciousness, or when serum sodium falls below 120 mmol/L, the clinical situation demands urgent, structured intervention to prevent irreversible neurological injury.
Clinical Scenario
This protocol applies to patients with SIADH who have severe neurological manifestations of hyponatremia — specifically seizures, coma, or significantly altered level of consciousness — and/or a serum sodium concentration below 120 mmol/L.
Treatment approach (partial overview): Urgent management centres on hypertonic saline to rapidly correct serum sodium. Additional pharmacological measures may be required depending on clinical status. Full regimen →
Therapeutic Goal
Urgent correction of serum sodium sufficient to reverse the most serious neurological manifestations of acute hyponatremia, with resolution of severe symptoms.
References
DOI: 10.1016/j.amjmed.2013.07.006
- Acute symptomatic hyponatremia is best corrected with hypertonic (3%) saline given either via bolus or continuous intravenous infusion.
- Severe, symptomatic hyponatremia should be treated with 3% NaCl, as this provides a quicker and more certain correction of serum [Na⁺] than vaptans.
- A review of the limited available literature concluded that a 4- to 6-mmol/L increase in serum [Na⁺] is sufficient to reverse the most serious manifestations of acute hyponatremia.
- For severe symptoms, the first day's increase can be accomplished during the first 6 hours of therapy, with subsequent increases postponed until the next day.
View source ↗